|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
| ||||||||||||||||||||
Files in this Data Supplement:
Fig. S1. The elbow joint interzone failed to form in Ptch1c−;Catnbc/−; Col2a1-Cre mutant embryo. Consecutive sections of the developing forelimbs at 12.5 dpc were examined by Alcian Blue/Nuclear Fast Red staining and in situ hybridization with the indicated 35S-labelled riboprobes. Elbow joint/interzone formation is indicated by lighter Alcian Blue staining and the differentiation of fibroblast-like cells in the joint/interzone area (arrows). Col2a1 expression was lost and Gdf5, the joint/interzone marker, was strongly expressed in the joint/interzone region (arrows). In the Ptch1c/−;Catnbc/−; Col2a1-Cre mutant limb there was a continuous Alcian Blue staining in the presumptive elbow joint/interzone region without differentiation of fibroblast-like cells (arrowhead). Persistent strong Col2a1 expression and loss of Gdf5 expression were also observed (arrowhead). In the Ptch1c/−;Catnbc/−; Col2a1-Cre mutant limb examined for Gdf5 expression, skeletal elements were outlined by dotted lines.
Fig. S2. Blocking Bmp signaling by noggin treatment rescued Gdf5 expression that was lost in the fused humerus-scapula joint in the Ptch1c/−;Catnbc/−; Col2a1-Cre mutant limb. In situ hybridization with 35S-labelled riboprobes of Gdf5 was performed on sections of the forelimbs that were isolated from 12.5 dpc embryos and cultured in vitro for 4 days. Gdf5 expression in the humerus-scapula joint is indicated by an arrow. Noggin treatment increased Gdf5 expression in the wild-type limb. In the Ptch1c/−;Catnbc/−; Col2a1-Cre mutant limb, Gdf5 expression was lost in the fused humerus-scapula joint (arrowhead). In the Ptch1c/−;Catnbc/−; Col2a1-Cre mutant limb treated with noggin, Gdf5 expression was rescued significantly in the humerus-scapula joint.
| ||||||||||||||||||||